Mersana Therapeutics Inc (MRSN) stock has fallen -75.12% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MRSN stock a score of 31 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 3. MRSN's rank also includes a short-term technical score of 5. The fundamental score for MRSN is 87. In addition to the average rating from Wall Street analysts, MRSN stock has a mean target price of $19.60. This means analysts expect the stock to increase 375.73% over the next 12 months.
MRSN has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on MRSN!
Mersana Therapeutics Inc (MRSN) stock has risen 0.73% while the S&P 500 has risen 0.95% as of 10:39 AM on Thursday, Apr 21. MRSN has risen $0.03 from the previous closing price of $4.09 on volume of 1,528,726 shares. Over the past year the S&P 500 has gained 7.87% while MRSN has fallen -75.12%. MRSN lost -$2.41 per share in the over the last 12 months.
Click Here to get the full Stock Report for Mersana Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
